Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry

Journal of Mass Spectrometry

Volumn 43, Issue 3, 2008, Pages 394-408

  Pozo, Oscar J ^a,b   Van Thuyne, Wim ^a   Deventer, Koen ^a   Van Eenoo, Peter ^a   Delbeke, Frans T ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITAT JAUME I   (Spain)

Author keywords

Accurate mass; Anabolic steroids; Doping analysis; Fluoxymesterone; Metabolites; Neutral loss; QTOF MS

Indexed keywords

ELECTROSPRAY IONIZATION; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ANABOLIC STEROIDS; DOPING ANALYSIS; FRAGMENTATION PATHWAY;

METABOLITES;

FLUOXYMESTERONE;

ANALYTIC METHOD; ARTICLE; CHEMICAL STRUCTURE; COLLISIONALLY ACTIVATED DISSOCIATION; DIAGNOSTIC ACCURACY; DOPING; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION TRAP MASS SPECTROMETRY; IONIZATION; MASS FRAGMENTOGRAPHY; PH MEASUREMENT; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE PH;

ANABOLIC AGENTS; CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; FLUOXYMESTERONE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR STRUCTURE; REFERENCE STANDARDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 40649086179     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1343     Document Type: Article

References (26)

1. Stanley SMR, Kent S, Rodgers JP. Biotransformation of 17-alkyl steroids in the equine: high-performance liquid chromatography-mass spectrometric and gas chromatography-mass spectrometric analysis of fluoxymesterone metabolites in urine samples. Journal of Chromatography B 1997; 704: 119.
2. Eschbach JW, Adamson JW. Improvement in anemia of chronic-renal failure with fluoxymesterone. Annals Internal Medicine 1973; 78: 527.
3. WADA. The World Anti-doping Code, The 2007 Prohibited List, International Standards, 2007; http://www.wada-ama.org/rtecontent/document/ 2007_List_En.pdf.
4. Van Eenoo P, Delbeke FT. Metabolism and excretion of anabolic steroids in doping control: new steroids and new insights. The Journal of Steroid Biochemistry and Molecular Biology 2006; 101: 161.
5. Schänzer W, Donike M. Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroids metabolites. Analytica Chimica Acta 1993; 275: 23.
6. Kammerer RC, Merdink JL, Jagels M, Catlin DH, Hui KK. Testing for fluoxymesterone (Halostin®) administration to man: identification of urinary metabolites by gas chromatography-mass spectrometry. Journal of Steroid Biochemistry 1990; 36: 659.
7. Thevis M, Schänzer W. Mass spectrometry in sports drug testing: structure characterization and analytical assays. Mass Spectrometry Reviews 2007; 26: 79.
8. Leinonen A, Kuuranne T, Kotiaho T, Kostiainen R. Screening of free 17-alkyl-substituted anabolic steroids in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 2004; 69: 101.
9. Deventer K, Van Eenoo P, Delbeke FT. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry. Biomedical Chromatography 2006; 20: 429.
10. Mazzarino M, Botrè F. A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti-oestrogen drugs and synthetic anabolic steroids. Rapid Communications in Mass Spectrometry 2006; 20: 3465.
11. Kim Y, Jun M, Lee W. Characterization of boldione and its metabolites in human urine by liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20: 9.
12. Schänzer W, Geyer H, Fußhöller G, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine. Rapid Communications in Mass Spectrometry 2006; 20: 2252.
13. Deventer K, Van Eenoo P, Mikulcikova P, Van Thuyne W, Delbeke FT. Quantitative analysis of androst-4-ene-3,6,17-trione and metabolites in human urine after the administration of a food supplement by liquid chromatography/iontrap-mass spectrometry. Journal of Chromatography B 2005; 828: 21.
14. Van Thuyne W, Van Eenoo P, Mikulcikova P, Deventer K, Delbeke FT. Detection of androst-4-ene-3,6,17-trione (6-OXO®) and its metabolites in urine by gas chromatography-mass spectrometry in relation with doping analysis. Biomedical Chromatography 2005; 19: 689.
15. Sangiorgi E, Curatolo M, Assini W, Bozzoni E. Application of neutral loss mode in liquid chromatography mass spectrometry for the determination of corticosteroids in bovine urine. Analytica Chimica Acta 2003; 483: 259.
16. Thevis M, Geyer H, Mareck U, Schnzer W. Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry 2005; 40: 955.
17. Pozo OJ, Deventer K, Van Eenoo P, Delbeke FT. Presence of endogenous interferences in the urinary detection of selected anabolic steroids by liquid chromatography electrospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2007; 21: 2785.
18. Pozo OJ, Van Eenoo P, Deventer K, Delbeke FT. Ionization of anabolic steroids by adduct formation in liquid chromatography mass spectrometry. Journal of Mass Spectrometry 2007; 42: 497.
19. Grimalt S, Pozo OJ, Marín JM, Sancho JV, Hernández F. Evaluation of different quantitative approaches for the determination of non-easily ionisable molecules by different atmospheric pressure interfaces used in liquid chromatography tandem mass spectrometry: Abamectin as a case of study. Journal of the American Society of Mass Spectrometry 2005; 16: 1619.
20. Thevis M, Schánzer W. Mass spectrometry in doping control analysis. Current Organic Chemistry 2005; 9: 825.
21. Borges CR, Taccogno J, Crouch DJ, Le L, Truong TN. Structure and mechanism of formation of an important ion in doping control. International Journal of Mass Spectrometry 2005; 247: 48.
22. Schánzer W, Horning S, Donike M. Metabolism of anabolic steroids in humans: synthesis of 6β-hydroxy metabolites of 4-chloro-1,2-dehydro- 17α-methyltestosterone, fluoxymesterone and metandienone. Steroids 1995; 60: 353.
23. Rang PH, Dale MM, Ritter JM. In Pharmacology, 3rd ed. Churchill Livinstong: Edinburgh; 1995.
24. Gatti R, Cappellin E, Zecchin B, Antonelli G, Spinella P, Mantero F, De Palo EF. Urinary high performance reverse phase chromatography cortisol and cortisone analyses before and at the end of a race in elite cyclists. Journal of Chromatography B 2005; 824: 51.
25. Ayotte C, Goudreault D, Charlebois A. Testing for natural and synthetic anabolic agents in human urine. Journal of Chromatography B 1996; 687: 3.
26. Saugy M, Cardis C, Robinson N, Schweizer C. Test methods: anabolics. Best Practice and Research Clinical Endocrinology and Metabolism 2000; 14: 111.